Exact Mass: 736.3704

Myxochromide S2

C39H56N6O8 (736.4159)

PG(i-12:0/5-iso PGF2VI)

C36H65O13P (736.4163)

PG(i-12:0/5-iso PGF2VI) is an oxidized phosphatidylglycerol (PG). Oxidized phosphatidylglycerols are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PG(i-12:0/5-iso PGF2VI), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of 5-iso Prostaglandin F2alpha-VI at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGs can be synthesized via three different routes. In one route, the oxidized PG is synthetized de novo following the same mechanisms as for PGs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PG backbone, mainly through the action of LOX (PMID: 33329396).

PG(5-iso PGF2VI/i-12:0)

C36H65O13P (736.4163)

PG(5-iso PGF2VI/i-12:0) is an oxidized phosphatidylglycerol (PG). Oxidized phosphatidylglycerols are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PG(5-iso PGF2VI/i-12:0), in particular, consists of one chain of one 5-iso Prostaglandin F2alpha-VI at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGs can be synthesized via three different routes. In one route, the oxidized PG is synthetized de novo following the same mechanisms as for PGs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PG backbone, mainly through the action of LOX (PMID: 33329396).

Saundersioside D

C39H60O13 (736.4034)

Cononitarine A

C43H52N4O7 (736.3836)

Leupyrrin A2

C41H56N2O10 (736.3935)

Leupyrrin B1

C41H56N2O10 (736.3935)

Conodiparine F

C43H52N4O7 (736.3836)

conodiparine E

C43H52N4O7 (736.3836)

callophylline A

C43H52N4O7 (736.3836)

1beta-hydroxyspirosta-5,25(27)-dien-3beta-yl O-alpha-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranoside

C39H60O13 (736.4034)

callophylline B

C43H52N4O7 (736.3836)

29-O-[3-O-Methyl-2-sulfato-beta-D-xylopyranoside-(3beta,5alpha,6alpha,7alpha,8beta,15beta,16beta,22E,24R)-Stigmast-22-ene-3,6,7,8,15,16,29-heptol

C35H60O14S (736.3704)

(8R,17R)-4beta-acetoxy-3beta-[(O-beta-D-glucopyranosyl-(1->4)-alpha-D-oleandropyranosyl)oxy]-14-oxo-5alpha-15(14->8)-abeo-card-20(22)-enolide|funingenoside I

C38H56O14 (736.367)

3-O-??-L-Rhamnopyranosyl (1鈥樏傗垎2)-??-D-glucuronopyranosyl-3??-hydroxy-25R-spirost-5-ene|3-O-??-L-Rhamnopyranosyl (1鈥樏傗垎2)-??-D-glucuronopyranosyl-3??-hydroxy-25S-spirost-5-ene

C39H60O13 (736.4034)

angusticraline

C44H56N4O6 (736.42)

PF-1057C

C35H60O12S2 (736.3526)

thevetioside E

C38H56O14 (736.367)

conofoline

C43H52N4O7 (736.3836)

dichotellide M|Trivial name of the compound not found in of the reference source

C37H52O15 (736.3306)

gemmacolide AD

C37H52O15 (736.3306)

(3beta,25R)-3-hydroxyspirost-5-en-7-one-3-O-alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside

C39H60O13 (736.4034)

lilioglycoside C

C39H60O13 (736.4034)

26-O-[3-O-Methyl-2-sulfate-beta-D-xylopyranoside-(3beta,5alpha,6alpha,7alpha,8beta,15beta,16beta,22E,24?鈥?25?鈥?-Stigmast-22-ene-3,6,7,8,15,16,26-heptol

C35H60O14S (736.3704)

Kingianoside B

C39H60O13 (736.4034)

cucurbitacin A 2-O-beta-D-glucopyranoside

C38H56O14 (736.367)

C43H60O10

C43H60O10 (736.4186)

Ornibactin C8

C30H56N8O13 (736.3967)

OKOHA-PI

C34H57O15P (736.3435)

OHDdiA-PG

C36H65O13P (736.4163)

Alcuronium Chloride

C44H50Cl2N4O2 (736.3311)

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002491 - Central Nervous System Agents

d(+)glucose-1,6-diphosphate, tetracyclohexylammonium salt

C30H66N4O12P2 (736.4152)

Perisoxal citrate

C38H48N4O11 (736.3319)

PG(i-12:0/5-iso PGF2VI)

C36H65O13P (736.4163)

PG(5-iso PGF2VI/i-12:0)

C36H65O13P (736.4163)

[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C36H65O13P (736.4163)

[1-heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C36H65O13P (736.4163)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-octanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C36H65O13P (736.4163)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C36H65O13P (736.4163)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-nonanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C36H65O13P (736.4163)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C36H65O13P (736.4163)

[1-decanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C36H65O13P (736.4163)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C36H65O13P (736.4163)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C36H65O13P (736.4163)

[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C36H65O13P (736.4163)

[(2S)-2-decanoyloxy-3-[hydroxy-[(5S)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C36H65O13P (736.4163)

[(2R)-1-decanoyloxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C36H65O13P (736.4163)

SMGDG O-27:3;O

C36H64O13S (736.4067)

SQDG 27:2;O

C36H64O13S (736.4067)

SQDG 29:8

C38H56O12S (736.3492)

HBMP 33:7

C39H61O11P (736.3951)

PG 18:0/12:3;O3

C36H65O13P (736.4163)

PG 18:1/12:2;O3

C36H65O13P (736.4163)

PG 20:5/13:3;O

C39H61O11P (736.3951)

PG 22:0/8:3;O3

C36H65O13P (736.4163)

PG 22:1/8:2;O3

C36H65O13P (736.4163)

PG 22:6/11:2;O

C39H61O11P (736.3951)

PG 33:8;O

C39H61O11P (736.3951)

LPIP 22:0

C31H62O15P2 (736.3564)

PI O-20:0/7:3;O

C36H65O13P (736.4163)

PI O-25:5;O3

C34H57O15P (736.3435)

PI O-26:4;O2

C35H61O14P (736.3799)

PI O-27:3;O

C36H65O13P (736.4163)

PI P-16:0/11:2;O

C36H65O13P (736.4163)

PI P-18:0/8:3;O2

C35H61O14P (736.3799)

PI P-18:1/7:3;O3

C34H57O15P (736.3435)

PI P-18:1/8:2;O2

C35H61O14P (736.3799)

PI P-18:1/9:1;O

C36H65O13P (736.4163)

PI 14:0/12:3;O

C35H61O14P (736.3799)

PI 16:0/9:4;O2

C34H57O15P (736.3435)

PI 18:0/8:3;O

C35H61O14P (736.3799)

PI 18:1/7:3;O2

C34H57O15P (736.3435)

PI 18:2/7:2;O2

C34H57O15P (736.3435)

PI 18:2/8:1;O

C35H61O14P (736.3799)

PI 20:1/6:2;O

C35H61O14P (736.3799)

PI 20:3/5:1;O2

C34H57O15P (736.3435)

PI 22:2/4:1;O

C35H61O14P (736.3799)

PI 26:3;O

C35H61O14P (736.3799)

PI 10:0_17:2

C36H65O13P (736.4163)

PI 27:2

C36H65O13P (736.4163)

(7e,9r,12r,13r,17s,21r,22s)-12-(hydroxymethyl)-22-{[(2r,3z,4z)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7-tetraene-11,15,18-trione

C41H56N2O10 (736.3935)

2-{[6b-hydroxy-11b-methyl-10-methylidene-9-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclohexa[a]fluoren-3-yl]oxy}-4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl acetate

C38H56O14 (736.367)

12-(hydroxymethyl)-22-{[4-(5-methoxypentan-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

C41H56N2O10 (736.3935)

3-hydroxy-3-methyl-5-oxo-5-(7',9',13'-trimethyl-16'-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-5-ylmethoxy)pentanoic acid

C39H60O13 (736.4034)

methyl (1r,9r,10s,12r,13e,18s)-13-ethylidene-4-[(1r)-1-[(1s,12s,13r,16s,17r,18r)-16-hydroxy-7-methoxy-3,20-dimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8-tetraen-17-yl]ethyl]-5-methoxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C44H56N4O6 (736.42)

3-[(3s,6s,9s,12s,15s,16r)-5,8,11,14-tetrahydroxy-6,9,16-trimethyl-15-[(2e,4e,6e,8e,10e,12e,14e)-n-methylheptadeca-2,4,6,8,10,12,14-heptaenamido]-12-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-3-yl]propanimidic acid

C39H56N6O8 (736.4159)

(3s)-3-hydroxy-3-methyl-5-oxo-5-[(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-7',9',13'-trimethyl-16'-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-5-ylmethoxy]pentanoic acid

C39H60O13 (736.4034)

3-[5,8,11,14-tetrahydroxy-6,9,16-trimethyl-15-(n-methylheptadeca-2,4,6,8,10,12,14-heptaenamido)-12-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-3-yl]propanimidic acid

C39H56N6O8 (736.4159)

(7e,9s,12r,13r,17s,21r,22s)-12-(hydroxymethyl)-22-{[(2s,3z,4z)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7-tetraene-11,15,18-trione

C41H56N2O10 (736.3935)

3-o-α-l-rhamnopyranosyl(1→2)-β-d-glucu-ronopyranosyl-3β-hydroxy-25r-spirost-5-ene

C39H60O13 (736.4034)

{"Ingredient_id": "HBIN009096","Ingredient_name": "3-o-\u03b1-l-rhamnopyranosyl(1\u21922)-\u03b2-d-glucu-ronopyranosyl-3\u03b2-hydroxy-25r-spirost-5-ene","Alias": "NA","Ingredient_formula": "C39H60O13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18709","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-o-α-l-rhamnopyranosyl(1→2)-β-d-glucu-ronopyranosyl-3β-hydroxy-25s-spirost-5-ene

C39H60O13 (736.4034)

{"Ingredient_id": "HBIN009097","Ingredient_name": "3-o-\u03b1-l-rhamnopyranosyl(1\u21922)-\u03b2-d-glucu-ronopyranosyl-3\u03b2-hydroxy-25s-spirost-5-ene","Alias": "NA","Ingredient_formula": "C39H60O13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18710","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1r,2s,4s,6r,7s,8s,9r,10r,13s,14r,17s)-17-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-hydroxy-8,14-dimethyl-7-(2-methylprop-1-en-1-yl)-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-19-ene-10-carbaldehyde

C39H60O13 (736.4034)

(7e,17s)-12-(hydroxymethyl)-22-{[(3z,4z)-4-[(3e)-5-methoxypent-3-en-2-ylidene]-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7-tetraene-11,15,18-trione

C41H56N2O10 (736.3935)

methyl (1s,15r,17s,18s)-5-[(1s,12r,14s,15z,18s)-15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-17-[(1s)-1-hydroxyethyl]-6-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O7 (736.3836)

2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-14'-oloxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C39H60O13 (736.4034)

methyl 14-[2-(1,3-dimethoxy-3-oxoprop-1-en-2-yl)-3-ethyl-8-hydroxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-yl]-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate

C43H52N4O7 (736.3836)

methyl (1r,12s,13s,15r,16r,20r)-12-ethyl-16-[(1s,9r,12s,13s,15r,20r)-12-ethyl-8-methyl-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2,4,6-trien-4-yl]-4-hydroxy-5,6-dimethoxy-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2(7),3,5,9-tetraene-10-carboxylate

C43H52N4O7 (736.3836)

(3e,6r)-6-[(1r,2r,3as,3bs,8s,9ar,9br,11ar)-2-hydroxy-9b-(hydroxymethyl)-3a,6,6,11a-tetramethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C38H56O14 (736.367)

6-hydroxy-6-[2-hydroxy-9b-(hydroxymethyl)-3a,6,6,11a-tetramethyl-7,10-dioxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,8h,9h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-5-oxohept-3-en-2-yl acetate

C38H56O14 (736.367)

(7e,9s,12s,13r,16e,22r)-12-(hydroxymethyl)-22-{[(2s,3z,4z)-4-(5-methoxypentan-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

C41H56N2O10 (736.3935)

(1r,2s,4s,6r,7s,8s,9r,10r,13s,14r,17s)-17-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-hydroxy-8,14-dimethyl-7-(2-methylprop-1-en-1-yl)-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-19-ene-10-carbaldehyde

C39H60O13 (736.4034)

4,11-dimethyl (1s,4s,5r,6s,7s,8r,11s,12r,14s,15r)-12-(acetyloxy)-7-hydroxy-6-[(2s,4r,6r,9r,11s)-2-hydroxy-4-methoxy-11-methyl-7,10-dioxatetracyclo[6.3.1.0²,⁶.0⁹,¹¹]dodecan-9-yl]-6-methyl-14-[(2-methylbutanoyl)oxy]-3,9-dioxatetracyclo[6.6.1.0¹,⁵.0¹¹,¹⁵]pentadecane-4,11-dicarboxylate

C37H52O15 (736.3306)

(7e,9s,12s,13r,16e,21s,22r)-12-(hydroxymethyl)-22-{[(2s,3z,4z)-4-(5-methoxypentan-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

C41H56N2O10 (736.3935)

n-[3-(5-{3-[(1,5-dihydroxy-3-methylpent-2-en-1-ylidene)amino]propyl}-3,6-dihydroxy-2,5-dihydropyrazin-2-yl)propyl]-5-{[5-(n,5-dihydroxy-3-methylpent-2-enamido)-2-[(1-hydroxyethylidene)amino]pentanoyl]oxy}-3-methylpent-2-enimidic acid

C35H56N6O11 (736.4007)

(1s,2s,3s,4r,7s,8e,10z,12s,13r,14s,16r,17s)-2,12,14-tris(acetyloxy)-9-[(butanoyloxy)methyl]-3,17-dihydroxy-4,13,17-trimethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,10-dien-16-yl octanoate

C38H56O14 (736.367)

12-(hydroxymethyl)-22-{[4-(5-methoxypent-3-en-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7-tetraene-11,15,18-trione

C41H56N2O10 (736.3935)

(2e,4e)-8-hydroxy-n-[(1s)-1-{[(3s,7s,9r,13s,16s,19s)-15-hydroxy-9,13,16,17-tetramethyl-2,6,12,18-tetraoxo-5-oxa-1,11,14,17-tetraazatricyclo[17.3.0.0⁷,¹¹]docos-14-en-3-yl]-c-hydroxycarbonimidoyl}-2-phenylethyl]octa-2,4-dienimidic acid

C38H52N6O9 (736.3796)

16'-[(3,4-dihydroxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-10'-one

C39H60O13 (736.4034)

(1'r,3s,4's,7'z,8'r,9's)-7'-ethylidene-5'-{[(1'r,3s,4's,7'z,8'r,9's)-7'-ethylidene-1-methoxy-2-oxo-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-5'-yl]carbonyl}-1,6-dimethoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one

C42H48N4O8 (736.3472)

methyl 14-[2-(1,3-dimethoxy-3-oxoprop-1-en-2-yl)-3-ethyl-8-hydroxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-yl]-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate

C43H52N4O7 (736.3836)

methyl (1r,12s,13s,15r,16r,20r)-12-ethyl-16-[(1s,9s,12s,13s,15r,20r)-12-ethyl-8-methyl-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2,4,6-trien-3-yl]-4-hydroxy-5,6-dimethoxy-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2(7),3,5,9-tetraene-10-carboxylate

C43H52N4O7 (736.3836)

3-{[2-amino-5-(n,3-dihydroxyoctanamido)-1-hydroxypentylidene]amino}-3-{[1-({1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-4-(n-hydroxyformamido)butyl}-c-hydroxycarbonimidoyl)-2-hydroxyethyl]-c-hydroxycarbonimidoyl}-2-hydroxypropanoic acid

C30H56N8O13 (736.3967)

methyl 12-ethyl-16-{12-ethyl-8-methyl-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2(7),3,5-trien-3-yl}-4-hydroxy-5,6-dimethoxy-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2(7),3,5,9-tetraene-10-carboxylate

C43H52N4O7 (736.3836)

methyl (1r,14r,15r,18r,19r,20s)-14-[(2s,3r,12bs)-2-[(1e)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-3-ethyl-8-hydroxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-10-yl]-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate

C43H52N4O7 (736.3836)

(2s,3r,4r,5r,6s)-2-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1's,2r,2's,4's,7's,8'r,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-14'-oloxy]oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C39H60O13 (736.4034)

methyl (1s,15r,17s,18s)-5-[(1s,12r,14s,15e,18s)-15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-6-hydroxy-17-[(1s)-1-hydroxyethyl]-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O7 (736.3836)

n-(4-carbamimidamidobutyl)-1-(2-{[1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-methylpentanoyl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroindole-2-carboximidic acid

C35H56N6O11 (736.4007)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-3-(acetyloxy)-15-[(2r,3r,5r)-2-(acetyloxy)-5-[(1s)-1-(acetyloxy)-2-hydroxy-2-methylpropyl]oxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

C43H60O10 (736.4186)

(2e)-n-{3-[(2s,5s)-5-(3-{[(2e)-1,5-dihydroxy-3-methylpent-2-en-1-ylidene]amino}propyl)-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propyl}-5-{[(2s)-5-[(2e)-n,5-dihydroxy-3-methylpent-2-enamido]-2-[(1-hydroxyethylidene)amino]pentanoyl]oxy}-3-methylpent-2-enimidic acid

C35H56N6O11 (736.4007)

methyl (1r,14r,15r,18r,19r,20s)-14-[(2s,3r,12bs)-2-[(1e)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-3-ethyl-8-hydroxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-yl]-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate

C43H52N4O7 (736.3836)

(1'r,3s,4's,7'z,8'r,9's)-7'-ethylidene-5'-{[(1'r,3s,4's,8'r,9's)-7'-ethylidene-1-methoxy-2-oxo-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-5'-yl]carbonyl}-1,6-dimethoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one

C42H48N4O8 (736.3472)

(2r,3s,4r,5s,6s)-2-{[(3s,4ar,6ar,6bs,9s,10ar,11as,11bs)-6b-hydroxy-11b-methyl-10-methylidene-9-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclohexa[a]fluoren-3-yl]oxy}-4-methoxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl acetate

C38H56O14 (736.367)

(7e,9r,12r,13r,16e,21r,22s)-12-(hydroxymethyl)-22-{[(2r,3z,4z)-4-(5-methoxypentan-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

C41H56N2O10 (736.3935)

methyl 14-{2-[(1z)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-3-ethyl-8-hydroxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-yl}-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate

C43H52N4O7 (736.3836)

methyl (1r,14r,15r,18s,19r,20s)-14-[(2s,3r,12bs)-2-[(1e)-1,3-dimethoxy-3-oxoprop-1-en-2-yl]-3-ethyl-8-hydroxy-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizin-9-yl]-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate

C43H52N4O7 (736.3836)

3-(acetyloxy)-15-[2-(acetyloxy)-5-[1-(acetyloxy)-2-hydroxy-2-methylpropyl]oxolan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl benzoate

C43H60O10 (736.4186)

(2r,5r,7's,9's,13'r,16's)-16'-{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-10'-one

C39H60O13 (736.4034)

(1's,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,16's)-16'-{[(2r,3r,4r,5r,6r)-3,4-dihydroxy-6-methyl-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-en-10'-one

C39H60O13 (736.4034)

methyl 12-ethyl-16-{12-ethyl-8-methyl-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2,4,6-trien-4-yl}-4-hydroxy-5,6-dimethoxy-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2(7),3,5,9-tetraene-10-carboxylate

C43H52N4O7 (736.3836)

4,11-dimethyl (1s,4s,5r,6s,7s,8r,11s,12r,14s,15r)-12-(acetyloxy)-7-hydroxy-6-[(2s,4s,6r,9r,11s)-2-hydroxy-4-methoxy-11-methyl-7,10-dioxatetracyclo[6.3.1.0²,⁶.0⁹,¹¹]dodecan-9-yl]-6-methyl-14-[(2-methylbutanoyl)oxy]-3,9-dioxatetracyclo[6.6.1.0¹,⁵.0¹¹,¹⁵]pentadecane-4,11-dicarboxylate

C37H52O15 (736.3306)

methyl (13z)-13-ethylidene-4-(1-{16-hydroxy-7-methoxy-3,20-dimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8-tetraen-17-yl}ethyl)-5-methoxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C44H56N4O6 (736.42)

methyl (1s,15r,17s,18s)-7-[(1s,12s,14r,15e,18s)-15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-17-[(1s)-1-hydroxyethyl]-6-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O7 (736.3836)

methyl (13e)-13-ethylidene-4-(1-{16-hydroxy-7-methoxy-3,20-dimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8-tetraen-17-yl}ethyl)-5-methoxy-8-methyl-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵]octadeca-2,4,6-triene-18-carboxylate

C44H56N4O6 (736.42)

(7e,16e)-12-(hydroxymethyl)-22-{[(3z,4z)-4-(5-methoxypentan-2-ylidene)-2-(2-methylpropyl)oxolan-3-ylidene]methyl}-8,12-dimethyl-17-(2-methylpropyl)-10,14,19,24-tetraoxa-23,25-diazatetracyclo[19.2.1.1²,⁵.0⁹,¹³]pentacosa-1(23),2,4,7,16-pentaene-11,15,18-trione

C41H56N2O10 (736.3935)

methyl (1s,15r,17s,18s)-5-[(1s,12r,14r,15e,18s)-15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-17-[(1s)-1-hydroxyethyl]-6-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O7 (736.3836)

methyl (1s,15r,17s,18s)-7-[(1s,12r,14s,15z,18s)-15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-17-[(1s)-1-hydroxyethyl]-6-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O7 (736.3836)

17-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-6-hydroxy-8,14-dimethyl-7-(2-methylprop-1-en-1-yl)-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-19-ene-10-carbaldehyde

C39H60O13 (736.4034)

(1s,2r,4s,6s,7r,8r,9s,10s,13r,14r,17r)-17-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4s,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-6-hydroxy-8,14-dimethyl-7-(2-methylprop-1-en-1-yl)-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-19-ene-10-carbaldehyde

C39H60O13 (736.4034)

methyl (1s,15r,17s,18s)-5-[(1s,12r,14s,15z,18s)-15-ethylidene-18-(hydroxymethyl)-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-6-hydroxy-17-[(1s)-1-hydroxyethyl]-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C43H52N4O7 (736.3836)

methyl (1r,12s,13s,15r,16r,20r)-12-ethyl-16-[(1s,9s,12s,13s,15r,20r)-12-ethyl-8-methyl-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2,4,6-trien-4-yl]-4-hydroxy-5,6-dimethoxy-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2(7),3,5,9-tetraene-10-carboxylate

C43H52N4O7 (736.3836)